Cargando…

The mechanisms of atrial fibrillation in hyperthyroidism

Atrial fibrillation (AF) is a complex condition with several possible contributing factors. The rapid and irregular heartbeat produced by AF increases the risk of blood clot formation inside the heart. These clots may eventually become dislodged, causing embolism, stroke and other disorders. AF occu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielecka-Dabrowa, Agata, Mikhailidis, Dimitri P, Rysz, Jacek, Banach, Maciej
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680813/ https://www.ncbi.nlm.nih.gov/pubmed/19341475 http://dx.doi.org/10.1186/1756-6614-2-4

Ejemplares similares

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

Malignancy-Associated Dyslipidemia
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2011)

The Rise and Fall of Hypertension: Lessons Learned from Eastern Europe
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2011)

The Relationship of Dehydration and Body Mass Index With the Occurrence of Atrial Fibrillation in Heart Failure Patients
por: Chuda, Anna, et al.
Publicado: (2021)

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2020)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018)

Established and potential echocardiographic markers of embolism and their therapeutic implications in patients with ischemic stroke
por: Gąsiorek, Paulina E., et al.
Publicado: (2019)

Atrial Fibrillation and Hyperthyroidism
por: N, Jayaprasad, et al.
Publicado: (2005)

Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2019)

Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice
por: Chuda, Anna, et al.
Publicado: (2021)

Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2015)

Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications
por: Bikiewicz, Agata, et al.
Publicado: (2021)

The outcomes of hypertension treatment depending on gender in patients over 40 years of age
por: Paduszyńska, Aleksandra, et al.
Publicado: (2021)

Cardioprotective properties of leptin in patients with excessive body mass
por: Paduszyńska, Aleksandra, et al.
Publicado: (2020)

The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases
por: Leczycki, Patryk, et al.
Publicado: (2022)

Effects of Implementing Personalized Health Education in Ambulatory Care on Cardiovascular Risk Factors, Compliance and Satisfaction with Treatment
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology
por: Gąsiorek, Paulina, et al.
Publicado: (2019)

Factors of Persistent Limited Exercise Tolerance in Patients after COVID-19 with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2022)

Diagnostic Usefulness of Spiroergometry and Risk Factors of Long COVID in Patients with Normal Left Ventricular Ejection Fraction
por: Gryglewska-Wawrzak, Katarzyna, et al.
Publicado: (2023)

Atrial fibrillation and hyperthyroidism: A literature review
por: Reddy, Vivek, et al.
Publicado: (2017)

Menopause and women’s cardiovascular health: is it really an obvious relationship?
por: Ryczkowska, Kamila, et al.
Publicado: (2022)

The Importance of Optimal Hydration in Patients with Heart Failure—Not Always Too Much Fluid
por: Wittczak, Andrzej, et al.
Publicado: (2023)

Left Ventricular Diastolic Dysfunction as Predictor of Unfavorable Prognosis After ESUS
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Obesity and Body Mass Components Influence Exercise Tolerance and the Course of Hypertension in Perimenopausal Women
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2022)

Association of inflammation with atrial fibrillation in hyperthyroidism
por: Ozaydin, Mehmet, et al.
Publicado: (2012)

Clinical outcomes of atrial fibrillation with hyperthyroidism
por: Zubair Khan, Muhammad, et al.
Publicado: (2021)

Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials
por: Hernandez, Adrian V., et al.
Publicado: (2023)

Predictors of Long COVID in Patients without Comorbidities: Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
por: Chudzik, Michał, et al.
Publicado: (2022)

Patient after correction Taussig‐Bing anomaly with severe neo‐aortic regurgitation after sudden cardiac arrest
por: Bielecka‐Dabrowa, Agata, et al.
Publicado: (2021)

The Atrial Fibrillation Risk Score for Hyperthyroidism Patients
por: Derevitskii, Ilya V., et al.
Publicado: (2020)

Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
por: Gencer, Baris, et al.
Publicado: (2022)

The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2023)

Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2021)

Prognostic value of left atrial volume index in acute coronary syndrome: A systematic review and meta‐analysis
por: Ahmeti, Artan, et al.
Publicado: (2021)

Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid Patients
por: Gürdoğan, Muhammet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rjfj2b47uc47la9ep2qdchrv45